Popular Posts

▼

Saturday, July 04, 2020

Trump Vindicated? New Peer-Reviewed Hydroxychloroquine Study Shows Reduced COVID-19 Mortality

A new large-scale study conducted by the Henry Ford Health System concluded that hydroxychloroquine, the anti-malaria drug touted by Trump as a potentially game-changing treatment for the coronavirus, successfully lowered mortality rates for hospitalized coronavirus patients. The results were published Thursday in the peer-reviewed International Journal of Infectious Diseases.

Just The News reported on its findings:

The study examined 2,541 patients who had been hospitalized in six hospitals between March 10 and May 2, 2020.

More than twenty-six percent (26.4%) of patients who did not receive hydroxychloroquine died.

But among those who received hydroxychloroquine, fewer than half that number — 13% — died.

More than 90% of the patients received hydroxychloroquine within 48 hours of admission to the hospital. Scientists say giving the drug early during illness may be a key to success.

The study also determined that there were no adverse effects on the heart, despite previous reports.

Will the mainstream media give this study the attention it deserves? I bet they won’t.

Hydroxychloroquine had several success stories ignored by the mainstream media
at

2 comments:

  1. AnonymousJuly 4, 2020 at 3:14 PM

    YES; Trump KNEW from the beginning this drug and drug combination would work!!!

    ReplyDelete
  2. anonymousJuly 4, 2020 at 3:36 PM

    Of course the Dems just made a treatment for a national emergency political. They just wanted our President to be wrong about everything. They actually made it hard to get lifesaving treatment to innocent American patients. This is a despicable way to treat the American people they are suppose to be serving.

    ReplyDelete

Note: Only a member of this blog may post a comment.